Gsk Share Discussion Threads

[abdullla] 27/6/2020 18:37

https://uk.finance.yahoo.com/news/gsk-quest-best-not-first-051949313.htmlThere is a notable name missing from the frontrunners in the race to test experimental immunisations against the novel coronavirus: the world's largest vaccine...

[jadeticl3] 26/6/2020 14:48

You may be right abdulla, if you are speaking personally, but Monty knew!!!

[abdullla] 26/6/2020 14:34

Yes TM those were the days we thought they would never end .

[tradermichael] 26/6/2020 12:28

Take a look at the 12-month chart and have a gentle reminder of how the price was motoring along at >1800p .....

[levisrus] 26/6/2020 11:20

My sell is set at 1772p

My Buy is set at 1574p

[levisrus] 26/6/2020 11:17

TA for GSK
3-10-16 Day moving average stalls 1668.743p
2nd Resistance 1670p
40 Day moving average stalls 1677p
1 month high 1693p

GSK across the pond in pre-market trading 41.29 usd

Have a great weekend and stay safe.

[geckotheglorious] 25/6/2020 10:21

We have a market!!!!

1570 - 1770

Cmon boyz. Close the B/O

[jamesretlaw] 25/6/2020 09:43

You mean 1670 .1770

[abdullla] 25/6/2020 09:32

1570 here we GO.

[sicker] 25/6/2020 09:22

monty, I've got a limit sell @£17, expires tomorrow. Still live in hope :-)

[montyhedge] 25/6/2020 08:15

1570p here we come.

[geckotheglorious] 24/6/2020 18:37

Reputation???
For £1bn R&D. And no payback.
We all know a couple of years down the line cash starved Govts will be back asking for "alleged" price gouging Pharmaceutical companies to pay their fair share.

[sicker] 24/6/2020 17:46

reputation monty

[montyhedge] 24/6/2020 15:49

What benefits in kind ?

[tradermichael] 24/6/2020 15:46

There will be 'benefits in kind'.

Also, the accountants will recover costs of research, labour, materials, plant etc. so they will not be running at a loss.

[montyhedge] 24/6/2020 15:15

That's good for the world, but I thought vaccine for Coronavirus was non profit making.

[tradermichael] 24/6/2020 10:20

Thanks, LEVISRUS:

Sanofi Moves Up Vaccine Rollout Timeline: Sanofi said it expects to begin a Phase 1/2 study of the recombinant protein vaccine candidate it is co-developing with GlaxoSmithKline in September, and full approval is likely to be obtained at the earliest by the first half of 2021, the company said at its Virtual R&D Investor Day.

GlaxoSmithKline is contributing its adjuvant AS03.

In mid-April, when the companies announced the collaboration, they gave a timeline of the second half of 2021 for the probable commercial launch of the vaccine.

"Sanofi is advancing the only vaccine in the race that's off a proven platform that works at scale," Fierce Pharma reported, quoting Sanofi CEO Paul Hudson.

Hudson expressed skepticism regarding the efficacy and the ability to scale manufacturing of the new breed of vaccines being developed by frontrunners working on the coronavirus.

[montyhedge] 24/6/2020 09:52

Retest 1570p coming.

[levisrus] 24/6/2020 09:14

Didn't expect this drop today.... I actually thought we would have tested 1687p.

Will add if we retest 1570p ish

gla

[alphorn] 24/6/2020 09:11

Apparently Sanofi is doing well with their vaccine candidate together with GSK. Talking mid 2021 as a date.

[abdullla] 24/6/2020 09:07

40p down what gives?

[geckotheglorious] 23/6/2020 10:30

AZN is better run, has a superior pipeline and isn't engaging in financial engineering(eg floating off Consumer Heathcare division) is why...

[barony] 23/6/2020 10:23

Why does Azn seem to be the darling of the press and gsk get ignored?